Outsourcing in Clinical Trials West Coast
March 1, 2023 - March 2, 2023

For the 15th Annual event, our flagship show will focus on providing delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials, this is an event not to be missed.
Why attend?
Arena International are delighted to announce Outsourcing in Clinical Trials West Coast will be returning to Burlingame for the annual event on March 1st & 2nd 2023!
Day 1 will kick off with a talk on designing a playbook for how to handle an undesirable CRO-Sponsor partnership, followed by a Keynote Panel allowing attendees to debate how to optimize their oversight & governance, led by Abby Kennedy (VP of Clinical Operations, CymaBay Therapeutics). Dan Solis from The FDA will give the closing keynote.
Genentech will give a case study session on piloting health inequities and gender identity data – why collecting this data now will aide you with your clinical trial.
The Patient Engagement track will be chaired by Estela Mata-Carcamo (Healthcare Advocate) and will delve into topics such as, outreach to minority groups, social determinants of health, and best practices for engaging the patient community. The Technology track will see Kimberley Ferguson (Commercial Head of Personalized Healthcare Partnerships, Genentech) discussing all things Wearables.
Don’t miss out; join us in Burlingame on March 1st & 2nd 2023!
https://www.arena-international.com/event/octwestcoast/
Hyatt San Francisco Airport, Burlingame, San Francisco
Upcoming Events

May 4, 2025
ASQ World Conference on Quality and Improvement 2025
Exhibiting: Booth # 115 We are excited to participate in the 2025 World Conference on Quality & Improvement to share how we’re pushing the boundaries of traditional quality practices. Our team is...

May 13, 2025
Veeva Commercial Summit 2025
Learn from industry leaders and make new connections at the largest gathering of commercial and medical professionals in life sciences. Whether you work at a large biopharma or an emerging biotech,...